Target type: biologicalprocess
Any process that modulates the frequency, rate or extent of nitrogen utilization. [GOC:go_curators]
Nitrogen utilization, a vital process for all life forms, is meticulously regulated to ensure optimal cellular function and survival. This intricate process involves a series of interconnected mechanisms that fine-tune the uptake, assimilation, and metabolism of nitrogen compounds. The regulation of nitrogen utilization is orchestrated at multiple levels, including transcriptional, translational, and post-translational control, and is influenced by both internal and external cues.
**1. Transcriptional Regulation:**
* **Nitrogen availability:** Cells monitor the availability of nitrogen in their environment, primarily through sensing the levels of ammonia (NH3) or its derivative glutamine (Gln). Low nitrogen levels trigger the expression of genes involved in nitrogen uptake and assimilation, while high levels suppress their expression.
* **Nitrogen source:** The type of nitrogen source available also impacts gene expression. For example, the presence of ammonium as a nitrogen source may preferentially activate genes involved in ammonium uptake and assimilation, while nitrate as a nitrogen source may activate genes involved in nitrate reduction.
* **Regulatory proteins:** Transcription factors like NtrC in bacteria and Gln3 in yeast play crucial roles in transcriptional regulation. These proteins respond to nitrogen availability and activate the expression of genes involved in nitrogen metabolism.
**2. Translational Regulation:**
* **Nitrogen availability:** Low nitrogen levels can affect the translation of mRNAs encoding proteins involved in nitrogen uptake and assimilation. This regulation often involves the presence of specific sequence elements within the mRNA that respond to nitrogen availability.
**3. Post-Translational Regulation:**
* **Enzyme activity:** Enzymes involved in nitrogen metabolism are subject to post-translational regulation, including phosphorylation, acetylation, and other modifications. These modifications can modulate enzyme activity, fine-tuning nitrogen utilization based on cellular needs.
* **Protein stability:** The stability of proteins involved in nitrogen metabolism can also be regulated. This regulation may involve the degradation of specific proteins under conditions of nitrogen depletion.
**4. Interplay of Internal and External Cues:**
* **Carbon availability:** Nitrogen utilization is often coupled with carbon metabolism. Cells need sufficient carbon sources to support nitrogen assimilation.
* **Energy availability:** Nitrogen assimilation requires energy, and cells prioritize energy production over nitrogen utilization under energy-limited conditions.
* **Stress responses:** Environmental stresses, such as osmotic stress or heat shock, can influence nitrogen utilization.
**In Summary:** The regulation of nitrogen utilization is a complex and multifaceted process that ensures efficient nitrogen utilization while maintaining cellular homeostasis. This intricate network of regulatory mechanisms involves sensing nitrogen availability, controlling gene expression, modulating enzyme activity, and responding to various internal and external cues. This precise regulation is essential for the growth, development, and survival of all living organisms.'
"
Protein | Definition | Taxonomy |
---|---|---|
Apoptosis regulator BAX | An apoptosis regulator BAX that is encoded in the genome of human. [PRO:SY, UniProtKB:Q07812] | Homo sapiens (human) |
Apoptosis regulator Bcl-2 | An apoptosis regulator Bcl-2 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P10415] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
catechin | hydroxyflavan | ||
chlorcyclizine | chlorcyclizine: was heading 1964-94 (Prov 1964-73); CHLOROCYCLIZINE & HISTACHLORAZINE were see CHLORCYCLIZINE 1977-94; use PIPERAZINES to search CHLORCYCLIZINE 1966-94; histamine H1-blocker used both orally and topically in allergies and also for the prevention of motion sickness | diarylmethane | |
gossypol | Gossypol: A dimeric sesquiterpene found in cottonseed (GOSSYPIUM). The (-) isomer is active as a male contraceptive (CONTRACEPTIVE AGENTS, MALE) whereas toxic symptoms are associated with the (+) isomer. | ||
vorinostat | vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL). Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME. | dicarboxylic acid diamide; hydroxamic acid | antineoplastic agent; apoptosis inducer; EC 3.5.1.98 (histone deacetylase) inhibitor |
alizarin | dihydroxyanthraquinone | chromophore; dye; plant metabolite | |
paclitaxel | Taxus: Genus of coniferous yew trees or shrubs, several species of which have medicinal uses. Notable is the Pacific yew, Taxus brevifolia, which is used to make the anti-neoplastic drug taxol (PACLITAXEL). | taxane diterpenoid; tetracyclic diterpenoid | antineoplastic agent; human metabolite; metabolite; microtubule-stabilising agent |
epigallocatechin gallate | (-)-epigallocatechin 3-gallate : A gallate ester obtained by the formal condensation of gallic acid with the (3R)-hydroxy group of (-)-epigallocatechin. epigallocatechin gallate: a steroid 5alpha-reductase inhibitor and antimutagen in green tea (Camellia sinensis) | flavans; gallate ester; polyphenol | antineoplastic agent; antioxidant; apoptosis inducer; geroprotector; Hsp90 inhibitor; neuroprotective agent; plant metabolite |
5,6,7,8-tetrahydro-1-naphthol | 5,6,7,8-tetrahydro-1-naphthol : 1-naphthol hydrogenated at C-5, -6, -7 and -8. | tetralins | |
epicatechin | (-)-epicatechin : A catechin with (2R,3R)-configuration. | catechin; polyphenol | antioxidant |
gallocatechol | (-)-epigallocatechin : A flavan-3,3',4',5,5',7-hexol having (2R,3R)-configuration. | catechin; flavan-3,3',4',5,5',7-hexol | antioxidant; food component; plant metabolite |
chelerythrine chloride | |||
epicatechin gallate | (-)-epicatechin-3-O-gallate : A gallate ester obtained by formal condensation of the carboxy group of gallic acid with the (3R)-hydroxy group of epicatechin. A natural product found in Parapiptadenia rigida. epicatechin gallate: a steroid 5alpha-reductase inhibitor; RN given refers to the (cis)-isomer; structure given in first source; isolated from green tea | catechin; gallate ester; polyphenol | EC 3.2.1.1 (alpha-amylase) inhibitor; EC 3.2.1.20 (alpha-glucosidase) inhibitor; metabolite |
blastmycin | blastmycin: structure | amidobenzoic acid | |
apogossypol | apogossypol: structure in first source | ||
umi-77 | UMI-77: an Mcl-1 inhibitor; structure in first source | ||
4-(4-ethoxycarbonylanilino)-2-quinazolinecarboxylic acid ethyl ester | quinazolines | ||
thioguanine anhydrous | Thioguanine: An antineoplastic compound which also has antimetabolite action. The drug is used in the therapy of acute leukemia. tioguanine : A 2-aminopurine that is the 6-thiono derivative of 2-amino-1,9-dihydro-6H-purine. Incorporates into DNA and inhibits synthesis. Used in the treatment of leukaemia. | 2-aminopurines | anticoronaviral agent; antimetabolite; antineoplastic agent |
ixabepilone | 1,3-thiazoles; beta-hydroxy ketone; epoxide; lactam; macrocycle | antineoplastic agent; microtubule-destabilising agent | |
abt-737 | aromatic amine; aryl sulfide; biphenyls; C-nitro compound; monochlorobenzenes; N-arylpiperazine; N-sulfonylcarboxamide; secondary amino compound; tertiary amino compound | anti-allergic agent; anti-inflammatory agent; antineoplastic agent; apoptosis inducer; B-cell lymphoma 2 inhibitor | |
nutlin-3a | nutlin 3: an MDM2 antagonist; structure in first source | stilbenoid | |
N-[4-(2-tert-butylphenyl)sulfonylphenyl]-2,3,4-trihydroxy-5-[(2-propan-2-ylphenyl)methyl]benzamide | benzamides | ||
MI-63 | MI-63 : An azaspiro compound resulting from the formal fusion of position 3 of 6-chloro-oxindole with position 3 of (2R,3SS5S)-3-(3-chloro-2-fluorophenyl)-5-(2,2-dimethylpropyl)-N-[2-(morpholin-4-yl)ethyl]pyrrolidine-2-carboxamide. It is a potent inhibitor of the MDM2-p53 interaction. | azaspiro compound; monochlorobenzenes; monofluorobenzenes; morpholines; oxindoles; pyrrolidines; secondary carboxamide | apoptosis inducer |
navitoclax | aryl sulfide; monochlorobenzenes; morpholines; N-sulfonylcarboxamide; organofluorine compound; piperazines; secondary amino compound; sulfone; tertiary amino compound | antineoplastic agent; apoptosis inducer; B-cell lymphoma 2 inhibitor | |
abt-199 | venetoclax : A member of the class of pyrrolopyridines that is a potent inhibitor of the antiapoptotic protein B-cell lymphoma 2. It is used for treamtment of chronic lymphocytic leukemia with 17p deletion. venetoclax: A BCL-2 inhibitor with antineoplastic activity that is used in the treatment of CHRONIC LYMPHOCYTIC LEUKEMIA associated with chromosome 17p deletion; structure in first source. | aromatic ether; C-nitro compound; monochlorobenzenes; N-alkylpiperazine; N-arylpiperazine; N-sulfonylcarboxamide; oxanes; pyrrolopyridine | antineoplastic agent; apoptosis inducer; B-cell lymphoma 2 inhibitor |
nvp-cgm097 | NVP-CGM097: an MDM2 and HDM2 inhibitor; structure in first source | ||
jy-1-106 | JY-1-106: a BH3 alpha-helix mimetic that functions as a pan-Bcl-2 inhibitor; structure in first source | ||
a-1155463 | A-1155463: a Bcl-X(L) inhibitor; structure in first source | ||
bm-1197 | BM-1197: inhibits both Bcl-xL and Bcl-2; has antineoplastic activity | ||
a-1331852 | A-1331852: a Bcl-X(L) inhibitor; structure in first source | ||
BDA-366 | BDA-366 : A member of the class of anthraquinone that is 1,4-diamino-9,10-anthraquinone in which the two amino groups are carrying 3-(diethylamino)-2-hydroxypropyl and (oxiran-2-yl)methyl substituents. It exhibits anti-cancer properties. BDA-366: has antineoplastic activity; binds Bcl-2 protein; structure in first source | anthraquinone; epoxide; secondary alcohol; secondary amino compound; tertiary amino compound | antineoplastic agent; apoptosis inducer |
apogossypolone | apogossypolone: has antineoplastic activity; structure in first source |